Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Queensland Health
QuintilesIMS
Merck
UBS
McKinsey

Generated: August 19, 2019

DrugPatentWatch Database Preview

Patent: 8,728,475

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,728,475
Title:Methods for treating inflammatory bowel disease
Abstract: Methods of treating inflammatory disorders, such as rheumatoid arthritis, by modulating TWEAK and TNF-.alpha. are disclosed, as are other methods.
Inventor(s): Burkly; Linda C. (West Newton, MA), Zheng; Timothy (Boston, MA)
Assignee: Biogen Idec MA Inc. (Cambridge, MA)
Application Number:13/246,197
Patent Claims:see list of patent claims

Details for Patent 8,728,475

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31   Try a Free Trial Biogen Idec MA Inc. (Cambridge, MA) 2025-05-10 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31   Try a Free Trial Biogen Idec MA Inc. (Cambridge, MA) 2025-05-10 RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Try a Free Trial Biogen Idec MA Inc. (Cambridge, MA) 2025-05-10 RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Chubb
McKinsey
Covington
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.